Valuation: Novartis AG

Market Cap 300B 257B 242B 221B 416B 28,627B 418B 2,856B 1,109B 14,438B 1,127B 1,102B 47,791B P/E 2026 *
22.4x
P/E 2027 * 19.1x
Enterprise Value 333B 286B 268B 245B 462B 31,745B 464B 3,167B 1,230B 16,010B 1,249B 1,222B 52,996B EV / Sales 2026 *
5.77x
EV / Sales 2027 * 5.35x
Free-Float
91.66%
Yield 2026 *
2.77%
Yield 2027 * 2.89%
Manager TitleAgeSince
Chief Executive Officer 50 2018-01-31
Director of Finance/CFO - 2026-03-15
Compliance Officer 58 2025-04-13
Director TitleAgeSince
Director/Board Member 67 2014-12-31
Director/Board Member 69 2015-12-31
Director/Board Member 61 2015-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-3.59%-2.96%+71.06%+114.83% 1,100B
-1.15%-0.41%+51.34%+62.41% 658B
-1.09%+1.54%+26.67%+79.22% 470B
-1.47%+2.05%+41.71%+42.09% 372B
-0.90%+1.29%+25.62%+41.75% 304B
-1.94%+1.53%+3.05%+13.24% 264B
-0.43%+3.54%+52.65%+71.75% 239B
-0.93%+2.90%-16.98%-52.28% 213B
-0.46%+3.24%+29.73%+92.67% 184B
Average -0.69%+3.01%+31.65%+51.74% 422.54B
Weighted average by Cap. -0.46%+2.21%+42.86%+68.24%

Financials

2026 *2027 *
Net sales 57.65B 49.47B 46.41B 42.4B 79.99B 5,500B 80.32B 549B 213B 2,774B 216B 212B 9,182B 61.31B 52.61B 49.36B 45.1B 85.07B 5,849B 85.42B 584B 227B 2,950B 230B 225B 9,765B
Net income 13.95B 11.97B 11.23B 10.26B 19.36B 1,331B 19.44B 133B 51.57B 671B 52.38B 51.24B 2,222B 15.5B 13.3B 12.48B 11.4B 21.51B 1,479B 21.6B 148B 57.3B 746B 58.2B 56.94B 2,469B
Net Debt 32.68B 28.04B 26.31B 24.04B 45.35B 3,118B 45.53B 311B 121B 1,572B 123B 120B 5,205B 27.82B 23.87B 22.4B 20.46B 38.6B 2,654B 38.76B 265B 103B 1,338B 104B 102B 4,431B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA